Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

U.S. Antitrust Officials Poised to Block Anthem, Aetna Deals

Reuters Staff  |  July 21, 2016

NEW YORK (Reuters)—U.S. antitrust officials are poised to file lawsuits to block Anthem Inc’s acquisition of Cigna Corp., as well as Aetna Inc.’s takeover of Humana Inc., a person familiar with the matter tells Reuters.

Antitrust regulators have been scrutinizing the deals and looking at the potential for higher prices if the insurance market consolidates so that Anthem, Aetna and UnitedHealth Group Inc., which is not involved in these deals, are the last three national health insurers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Skepticism that the Anthem-Cigna deal would pass muster has been high for most of that review process, but investors were betting that the Aetna-Humana combination was less troublesome and could be approved if the companies sold some assets.

The department’s decision could be announced by the end of next week, the source familiar with the matter added.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bloomberg first reported that the U.S. Justice Department had decided to sue to block the mergers.

Anthem, Cigna and Aetna declined to comment. Humana and the Justice Department were not immediately available for comment.

The two deals were announced about a year ago just weeks apart. Anthem officials said in May that the Justice Department was particularly concerned about its national large-employer business. Analysts have said it would be difficult to sell assets to meet those concerns.

Aetna’s purchase of Humana would combine two of the largest providers of Medicare Advantage plans for elderly people. Sources have told Reuters that the companies had presented a divestment plan and the names of possible buyers to the Justice Department less than two weeks ago.

Leerink Partners analyst Ana Gupte says in a research note that she expects the companies to fight the Department of Justice, but that Anthem’s and Cigna’s chances of success were slim.

She says she expects Humana and Cigna to use their strong cash positions to buy back shares or make small acquisitions. WellCare Health Plans, Molina Healthcare Inc and Centene Corp are possible targets, she said, though only WellCare is potentially open to a deal.

Share: 

Filed under:Legal Updates Tagged with:Anthem Inc.Cigna Corp.Department of JusticeHealth Insurancemerger

Related Articles

    U.S. Court Blocks Anthem-Cigna Deal

    February 9, 2017

    (Reuters)—A federal judge on Wednesday ruled against U.S. health insurer Anthem Inc.’s proposed $54 billion merger with smaller rival Cigna Corp, derailing an unprecedented effort to consolidate the country’s health insurance industry. The U.S. Department of Justice sued in July to stop Anthem’s purchase of Cigna, a deal that would have created the largest U.S….

    U.S. Regulators Sue to Block Anthem-Cigna & Aetna-Humana Mergers

    July 22, 2016

    NEW YORK (Reuters)—U.S. antitrust officials on Thursday moved to block an unprecedented consolidation of the national health insurance market, filing suit against Anthem Inc.’s proposed purchase of Cigna Corp. and Aetna Inc.’s planned acquisition of Humana Inc. The U.S. Department of Justice (DOJ) says the two mergers would reduce competition, raise prices for consumers and…

    U.S. Justice Department Has Concerns about Aetna-Humana Deal

    July 9, 2016

    (Reuters)—The U.S. Department of Justice has significant concerns about Aetna Inc.’s proposed acquisition of health insurer Humana Inc., a source familiar with the situation said on Thursday, and shares of Humana fell more than 11%. Aetna’s purchase of Humana would combine two of the largest providers of Medicare Advantage plans for elderly people, and investors…

    CVS Health to Acquire Aetna for $69 billion

    December 4, 2017

    (Reuters)—U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc. for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. This year’s largest corporate acquisition will combine one of the nation’s largest pharmacy benefits managers (PBMs) and pharmacy operators with…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences